Sirius Genomics Inc. - Product Pipeline Analysis

• Publication date: June 2012
• Report size: 15 pages

Sirius Genomics Inc. - Product Pipeline Analysis Summary Sirius Genomics (Sirius) is a biotechnology company, based in Canada. It develops diagnostic and pharmacogenetic products for the healthcare markets. The company’s product is a companion diagnostic for activated protein C. It is developing a companion diagnostic to stratify patients according to their ability to benefit from activated protein C. Sirius is developing a...

Sirius Genomics Inc. - Product Pipeline Analysis

Summary

Sirius Genomics (Sirius) is a biotechnology company, based in Canada. It develops diagnostic and pharmacogenetic products for the healthcare markets. The company’s product is a companion diagnostic for activated protein C. It is developing a companion diagnostic to stratify patients according to their ability to benefit from activated protein C. Sirius is developing a diagnostic kit offered near the bedside with the goal of identifying sepsis patients with a genotype statistically connected with improved survival after treatment with activated protein C. The company was incorporated in the year 2001. Sirius is headquartered in Vancouver, British Columbia, Canada.

This report is a source for data, analysis and actionable intelligence on the Sirius Genomics Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.

Genomics Industry in Canada

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Key Facts 4
Sirius Genomics Inc. - Major Products and Services 5
Sirius Genomics Inc. Pipeline Products by Equipment Type 6
Sirius Genomics Inc. Pipeline Products by Development Stage 7
Activated Protein C CDx 8
Activated Protein C CDx Product Status 8
Activated Protein C CDx Product Description 8
Anti - TNF CDx 9
Anti - TNF CDx Product Status 9
Anti - TNF CDx Product Description 9
Vasopressor CDx 10
Vasopressor CDx Product Status 10
Vasopressor CDx Product Description 10
Sirius Genomics Inc. - Key Competitors 11
Sirius Genomics Inc. - Key Employees 12
Sirius Genomics Inc. - Locations And Subsidiaries 13
Head Office 13
Recent Developments 14
Sirius Genomics Inc., Recent Developments 14
Oct 11, 2011: Sirius Genomics Launches Major International Sepsis Study 14
Appendix 15
Methodology 15
About GlobalData 15
Contact Us 15
Disclaimer 15
List of Tables


Sirius Genomics Inc., Key Facts 1
Sirius Genomics Inc. Key Pipeline Products by Equipment Type 1
Sirius Genomics Inc. Key Pipeline Products by Development Stage 1
Sirius Genomics Inc., Key Facts 4
Sirius Genomics Inc., Major Products and Services 5
Sirius Genomics Inc. Number of Pipeline Products by Equipment Type 6
Sirius Genomics Inc. Pipeline Products by Equipment Type 6
Sirius Genomics Inc. Number of Pipeline Products by Development Stage 7
Sirius Genomics Inc. Pipeline Products by Development Stage 7
Activated Protein C CDx - Product Status 8
Activated Protein C CDx - Product Description 8
Anti - TNF CDx - Product Status 9
Anti - TNF CDx - Product Description 9
Vasopressor CDx - Product Status 10
Vasopressor CDx - Product Description 10
Sirius Genomics Inc., Key Employees 12
List of Figures


Sirius Genomics Inc. Pipeline Products by Equipment Type 6
Sirius Genomics Inc. Pipeline Products by Development Stage 7